Kalpesh N Biyani

USPTO Granted Patents = 23 (Patent Applications = 11)

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 12 (Patent Applications = 16)

Average Co-Inventor Count = 6.5

ph-index = 6

Forward Citations = 87(Granted Patents)

Location History:

Fremont, CA (US) (2015 - 2020)
Newark, CA (US) (2013 - 2021)
Dublin, CA (US) (2018 - 2024)

Company Filing History:

Cambrios Film Solutions Corporation

Cam Holding Corporation

patents

6. 1 out of 9

Vifor (international) Ltd.

patents

Years Active: 2013-2024

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11992501 - Compositions for and methods of treating acid-base disorders (2024-05-28),

2. 11738041 - Proton-binding polymers for oral administration (2023-08-29),

3. 11406661 - HCl-binding compositions for and methods of treating acid-base disorders (2022-08-09),

4. 11311571 - Proton-binding polymers for oral administration (2022-04-26),

5. 11197887 - Proton-binding polymers for oral administration (2021-12-14),

6. 10934380 - Crosslinked poly(allylamine) polymer pharmaceutical compositions (2021-03-02),

7. 10905711 - Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal (2021-02-02),

8. 10852614 - Method of forming electrical contacts in layered structures (2020-12-01),

9. 10391118 - Proton-binding polymers for oral administration (2019-08-27),

10. 10369169 - Proton-binding polymers for oral administration (2019-08-06),

11. 10363268 - Proton-binding polymers for oral administration (2019-07-30),

12. 10324352 - Method of forming metal nanostructure-based structure (2019-06-18),

13. 10272103 - Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants (2019-04-30),

14. 10058567 - Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal (2018-08-28),

15. 9993500 - Proton-binding polymers for oral administration (2018-06-12),

Title: Innovator Spotlight: Kalpesh N. Biyani

Introduction: Kalpesh N. Biyani, an accomplished inventor based in Dublin, California, has made significant contributions to the field of pharmaceutical sciences. With a track record of 23 patents, he is recognized for his innovative approaches to treating acid-base disorders through novel compositions and methods.

Latest Patents: Kalpesh N. Biyani’s latest patents focus on groundbreaking pharmaceutical compositions. One of his notable patents is for "Compositions for and methods of treating acid-base disorders." This invention involves pharmaceutical compositions that can be used to treat diseases by normalizing serum bicarbonate concentrations and blood pH levels in humans and animals. Another significant patent, "Proton-binding polymers for oral administration," describes compositions that utilize crosslinked amine polymers to effectively manage metabolic conditions by removing protons and chloride ions from the gastrointestinal tract.

Career Highlights: Throughout his career, Kalpesh has been associated with key companies in the pharmaceutical industry, notably Tricida, Inc. and Relypsa, Inc. His innovative work has led to advancements in medical treatments, showcasing his dedication to improving patient health through scientific research and development.

Collaborations: In his professional journey, Kalpesh has collaborated with talented individuals, including his coworkers Eric F. Connor and Michael James Cope. These collaborations have contributed to his success and the innovative solutions he offers in the area of pharmaceuticals.

Conclusion: Kalpesh N. Biyani exemplifies the spirit of innovation in the pharmaceutical field. With 23 patents to his name and a focus on enhancing treatments for acid-base disorders, his contributions continue to impact healthcare positively. His work serves as an inspiration for aspiring inventors and reinforces the importance of innovation in the life sciences.

This text is generated by artificial intelligence and may not be accurate.